Literature DB >> 34181446

Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.

Swathi Sangli1, Ahmed Virani1, Nicholas Cheronis1, Brittany Vannatter1, Corbyn Minich1, Shaun Noronha1, Rama Bhagavatula1, Daniel Speredelozzi1, Meera Sareen1, Robert B Kaplan1.   

Abstract

Entities:  

Year:  2021        PMID： 34181446     DOI： 10.7326/L21-0244

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  39 in total

1.  Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation.

Authors:  Abdullahi E Mahgoub; Dominic Awuah; MurtazaShabbir Hussain; Smit Deliwala; Ghassan Bachuwa; Mariam Younas
Journal:  Cureus       Date:  2022-02-13

2.  Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.

Authors:  Patricia Mouta Nunes de Oliveira; Daniela P Mendes-de-Almeida; Victor Bertollo Gomes Porto; Catherine Crespo Cordeiro; Gabriellen Vitiello Teixeira; Renata Saraiva Pedro; Paulo Roberto Gomes Takey; Letícia Kegele Lignani; Janaína Reis Xavier; Vitor Cardoso Doria da Gama; Luiz Amorim Filho; Bárbara Emoingt Furtado; André Santa Maria; Tiago Dahrug Barros; Livia Neves Waite Freitas; Tainá Dos Santos Pereira; Debora Lima Abreu; Michael Bernardes Ramos; Caroline Gabe; Donald Arnold; James William Smith; Ishac Nazy; Maria de Lourdes de Sousa Maia
Journal:  Vaccine       Date:  2022-06-16       Impact factor: 4.169

Review 3.  COVID-19 Vaccines: Adenoviral Vectors.

Authors:  Catherine Jacob-Dolan; Dan H Barouch
Journal:  Annu Rev Med       Date:  2021-10-05       Impact factor: 13.739

4.  Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.

Authors:  Angelo Cascio Rizzo; Giuditta Giussani; Elio Clemente Agostoni
Journal:  Cerebrovasc Dis       Date:  2022-05-05       Impact factor: 3.104

Review 5.  Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination.

Authors:  Danilo Toni; Alexander E Merkler; Manuela De Michele; Joshua Kahan; Irene Berto; Oscar G Schiavo; Marta Iacobucci
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

Review 6.  Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.

Authors:  Diana A Gorog; Robert F Storey; Paul A Gurbel; Udaya S Tantry; Jeffrey S Berger; Mark Y Chan; Daniel Duerschmied; Susan S Smyth; William A E Parker; Ramzi A Ajjan; Gemma Vilahur; Lina Badimon; Jurrien M Ten Berg; Hugo Ten Cate; Flora Peyvandi; Taia T Wang; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2022-01-13       Impact factor: 49.421

7.  Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.

Authors:  Sisse R Ostrowski; Ole S Søgaard; Martin Tolstrup; Nina B Stærke; Jens Lundgren; Lars Østergaard; Anne-Mette Hvas
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

8.  Lessons from vaccine-induced immune thrombotic thrombocytopenia.

Authors:  John Greenhow Kelton; Donald Mitchell Arnold; Ishac Nazy
Journal:  Nat Rev Immunol       Date:  2021-12       Impact factor: 53.106

Review 9.  Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome.

Authors:  Paolo Gresele; Stefania Momi; Rossella Marcucci; Francesco Ramundo; Valerio De Stefano; Armando Tripodi
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941

10.  Epidemiology of VITT.

Authors:  Menaka Pai
Journal:  Semin Hematol       Date:  2022-02-08       Impact factor: 3.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.